The TB Diagnostics Critical Pathway is intended to be a virtual knowledge management tool to document a  TB diagnostic innovator's path to the rapid introduction and widespread scale-up of promising new TB tools, indicating the critical activities, stakeholders and resources along the pathway.

This tool was developed based on the collective input from a breadth of TB and global health stakeholders, as a resource for diagnostic developers and wider TB community.

This website is currently a beta version, and we welcome your comments and ideas for improvement!

Partners Behind the Pathway


FIND (Foundation for Innovative New Diagnostics) is an international non-profit organization that enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola

McGill International TB Centre

The McGill International TB Centre, situated at the McGill University Health Centre in Montreal, Canada, is a world leader in the interdisciplinary study of TB, bringing together researchers in biomedical, clinical, epidemiological and social determinants of TB and other mycobacterial diseases.

Stop TB Partnership

The Stop TB Partnership is leading the way to a world without tuberculosis (TB), a disease that is curable but still kills three people every minute. Founded in 2001, the Partnership's mission is to serve every person who is vulnerable to TB and ensure that high-quality diagnosis, treatment and care is available to all who need it. They operate through a secretariat hosted by UNOPS in Geneva, Switzerland and seven working groups whose role is to accelerate progress on access to TB diagnosis and treatment; research and development for new TB diagnostics, drugs and vaccines; and tackling drug resistant- and HIV-associated TB. The secretariat is governed by a Coordinating Board that sets strategic direction for the global fight against TB. The Partnership is recognized as a unique international body with the power to align actors all over the world in the fight against TB. The participation of a wide range of constituencies gives us credibility and the broad range of medical, social and financial expertises needed to defeat TB.


Unitaid is a hosted partnership of the World Health Organization (WHO) that invests in new ways to prevent, diagnose and treat HIV/AIDS, tuberculosis and malaria more quickly, more cheaply and more effectively


The World Health Organization is a specialized agency of the United Nations established in 1948 to further international cooperation for improved public health conditions. The WHO Global TB Programme is responsible for coordinating WHO's global efforts to end TB


We would like to acknowledge the important contributions and feedback from the TB community and global health organizations around the world.

Anita Suresh
Senior Technology & Business Development Officer
Caroline Vadnais
Research Manager, RI-MUHC
Jacqueline Huh
Team Leader, Strategic Initiatives & Innovative Financing
Chris Gilpin
Claudia Denkinger
Draurio Barreira Cravo Neto
Sahu Suvanand
Sara Padidar